Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the approval of ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), as a new first-line maintenance ...
We've rounded up the top website builders for small businesses, from Webflow's design power to Hostinger's budget-friendly AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results